Lv31
228 积分 2023-03-28 加入
63527 Vilobelimab Safety in Hidradenitis Suppurativa Patients in a Randomized, Placebo-Controlled, Double-Blind Multicenter Phase 2b study
2小时前
求助中
Discovery of HW201877: A Highly Potent and Orally Bioavailable Inhibitor of 15-Prostaglandin Dehydrogenase to Potentiate Tissue Repair and Regeneration
8天前
已完结
Gefapixant as a P2X3 receptor antagonist treatment for obstructive sleep apnea: a randomized controlled trial
12天前
已完结
Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trial
13天前
已关闭
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
28天前
已完结
VG081821: A ZM241385‐Like A2A Receptor Antagonist With Significant Improvement in Pharmacokinetics
1个月前
已完结
Istradefylline as monotherapy for Parkinson disease: Results of the 6002-US-051 trial
1个月前
已关闭
The effect and safety of levodopa alone versus levodopa sparing therapy for early Parkinson’s disease: a systematic review and meta-analysis
2个月前
已完结
Tasipimidine—the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist
2个月前
已完结
皖公网安备34019202002308
